Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial

Ojanguren Arranz, Iñigo; Pilia, María-Florencia

View

Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial, 2021 (96.41Kb)

Author

Ojanguren Arranz, Iñigo

Pilia, María-Florencia

Date

2021-03

Permanent link

https://hdl.handle.net/11351/7129

DOI

10.1183/20734735.0279-2020

ISSN

2073-4735

WOS

000626243000004

PMID

34295395

Show full item record

Abstract

Triple therapy with FF/UMEC/VI improved lung function in patients with moderate or severe uncontrolled asthma on ICS/LABA but did not lead to a reduction in moderate and/or severe exacerbations

Keywords

Efficacy and safety; Triple therapy; Inadequately controlled asthma

Bibliographic citation

Ojanguren I, Pilia MF. Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial. Breathe. 2021 Mar;17(1):200279.